Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model

被引：0
|
作者：
Nikolai Mühlberger
Kristijan Boskovic
Murray D. Krahn
Karen E. Bremner
Willi Oberaigner
Helmut Klocker
Wolfgang Horninger
Gaby Sroczynski
Uwe Siebert
机构：
[1] UMIT - University for Health Sciences,Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment
[2] Medical Informatics and Technology,Division of Health Technology Assessment
[3] ONCOTYROL - Center for Personalized Cancer Medicine,Toronto Health Economics and Technology Assessment (THETA) Collaborative
[4] University of Toronto,Department of Urology
[5] Toronto General Research Institute,Center for Health Decision Science, Department of Health Policy and Management
[6] Toronto General Hospital,Institute for Technology Assessment and Department of Radiology
[7] Cancer Registry of Tyrol,undefined
[8] Tirol Kliniken GmbH,undefined
[9] Medical University of Innsbruck,undefined
[10] Harvard T.H. Chan School of Public Health,undefined
[11] Massachusetts General Hospital,undefined
[12] Harvard Medical School,undefined
来源：
BMC Public Health | / 17卷
关键词：
Benefit-harm Balance; Quality-adjusted Life Expectancy (QALE); Elevated Familial Risk; Active Surveillance; Optimal Screening Strategy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model
    Muehlberger, Nikolai
    Boskovic, Kristijan
    Krahn, Murray D.
    Bremner, Karen E.
    Oberaigner, Willi
    Klocker, Helmut
    Horninger, Wolfgang
    Sroczynski, Gaby
    Siebert, Uwe
    [J]. BMC PUBLIC HEALTH, 2017, 17
  • [2] The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening
    Muehlberger, Nikolai
    Kurzthaler, Christina
    Iskandar, Rowan
    Krahn, Murray D.
    Bremner, Karen E.
    Oberaigner, Willi
    Klocker, Helmut
    Horninger, Wolfgang
    Conrads-Frank, Annette
    Sroczynski, Gaby
    Siebert, Uwe
    [J]. MEDICAL DECISION MAKING, 2015, 35 (06) : 758 - 772
  • [3] SCREENING FOR PROSTATE CANCER: SHAPING THE DEBATE ON BENEFITS AND HARMS
    Dahm, Philipp
    Neuberger, Molly
    Ilic, Dragan
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
  • [4] THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - HOW LATENT PREVALENCE AFFECTS THE BENEFIT-HARM BALANCE OF SCREENING
    Muehlberger, N.
    Heijnsdijk, E. A. M.
    Kurzthaler, C.
    Iskandar, R.
    Krahn, M. D.
    Bremner, K.
    Oberaigner, W.
    Klocker, H.
    Horninger, W.
    Conrads-Frank, A.
    Sroczynski, G.
    Siebert, U.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A559 - A559
  • [5] NEWSPAPER COVERAGE OF PROSTATE AND COLORECTAL CANCER SCREENING BENEFITS AND HARMS
    Elstad, Emily A.
    Sheridan, Stacey
    Brewer, Noel T.
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2014, 47 : S184 - S184
  • [6] Clinicians' Perceptions of the Benefits and Harms of Prostate and Colorectal Cancer Screening
    Elstad, Emily A.
    Sutkowi-Hemstreet, Anne
    Sheridan, Stacey L.
    Vu, Maihan
    Harris, Russell
    Reyna, Valerie F.
    Rini, Christine
    Earp, Jo Anne
    Brewer, Noel T.
    [J]. MEDICAL DECISION MAKING, 2015, 35 (04) : 467 - 476
  • [7] Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms
    Gulati, Roman
    Cheng, Heather H.
    Lange, Paul H.
    Nelson, Peter S.
    Etzioni, Ruth
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (02) : 222 - 227
  • [8] Screening for prostate cancer Consider the harms
    Bewley, Susan
    [J]. BRITISH MEDICAL JOURNAL, 2010, 341
  • [9] Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening
    Auvinen, Anssi
    Moss, Sue M.
    Tammela, Teuvo L. J.
    Taari, Kimmo
    Roobol, Monique J.
    Schroder, Fritz H.
    Bangma, Chris H.
    Carlsson, Sigrid
    Aus, Gunnar
    Zappa, Marco
    Puliti, Donella
    Denis, Louis J.
    Nelen, Vera
    Kwiatkowski, Maciej
    Randazzo, Marco
    Paez, Alvaro
    Lujan, Marcos
    Hugosson, Jonas
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (01) : 243 - 249
  • [10] Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms
    Vickers, Andrew J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2017, 167 (07) : 509 - 510
12345